|
⚲
|
| Lead Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001400100 |
| Sale | 2009-04-28 ($7.0 M Offered, $3.0 M Sold) |
| Fund | |
| Phone | 6507371630 |
| Address | 999 Bayhill Drive, Suite 130 San Bruno, 94066 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Shuang Qiao | |
| Alain Schreiber | |
| Leonard Post | |
| Peter Myers | |
| Arthur Pappas | |
| David Hanabusa |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
JE Fund I, a series of Unpopular VC, LP
✚
|
0.0 | |
|
JE Fund II, a series of Unpopular VC, LP
✚
|
0.0 | |
|
Jeifetz Martha V.
✚
|
0.0 | |
|
JEM Ventures Series 1
✚
|
0.0 | |
|
JEM Ventures Series 2
✚
|
0.0 | |
|
Jengu Therapeutics, Inc.
✚
|
0.0 | |
|
Jenkins David H
✚
|
0.0 | |
|
Jenkin Thomas M
✚
|
0.0 | |
|
Jennings Kevin
✚
|
0.0 | |
|
Jedar Capital Cohort 16, a Series of Assure Labs 2022, LLC
✚
|
0.0 |